Navigation Links
Genoptix Announces Participation at Lehman Brothers 11th Annual Global Health Care Conference

CARLSBAD, Calif., March 7 /PRNewswire-FirstCall/ -- Genoptix, Inc. (Nasdaq: GXDX), a specialized laboratory services provider, today announced the company's participation in the 11th Annual Lehman Brothers Global Health Care Conference at the Loews Miami Beach Hotel in South Beach, Fla., March 18 - 20, 2008.

Dr. Tina Nova Bennett, President and CEO of Genoptix, and Sam Riccitelli, COO, will present at the conference on Tuesday, March 18, 2008 beginning at approximately 10:45am EDT. They will provide an overview of the company's specialized diagnostic laboratory services business, growth strategies and 2007 financial results.

The presentation is expected to last approximately 30 minutes, followed by a short question and answer session, all of which will be webcast live on the Internet and accessible through the investor relations section of the Genoptix website at Listeners should go to this site at least 15 minutes prior to the event to register, download and install any necessary software. A replay will also be available for 30 days following the initial presentation webcast.

About Genoptix, Inc.

Genoptix is a specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to community-based hematologists and oncologists. Genoptix is headquartered in Carlsbad, California.

Forward-Looking Statements

This press release contains forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements. Actual results may differ materially from those projected. Genoptix disclaims, however, any intent or obligations to update these forward-looking statements.

SOURCE Genoptix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Genoptix Announces Participation at Cowen and Company 28th Annual Health Care Conference
2. Genoptix Announces Pricing of Secondary Public Offering
3. Genoptix Announces Filing of Registration Statement for Secondary Public Offering of Common Stock
4. Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 2007
5. Genoptix, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 12, 2008
6. Genoptix, Inc. Announces Pricing for Initial Public Offering
7. Susan G. Komen for the Cure(R) Announces Global Promise Fund to Help Women Worldwide
8. ACS Announces $57 Million Contract With Missouri HealthNet
9. Nfocus Neuromedical Announces Acquisition of StarFire Medical
10. QED International Associates Announces Changes to the HealthShares(TM) Composite and HealthShares(TM) Cancer Indexes
11. Pharos Innovations Announces First Recipient of National Award for Achievements in Chronic Care Programs and Research
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... An inventor, ... to dispense prescription medications at home, so he invented the patent-pending ELECTRONIC M.D. ... dispense prescription medications. In doing so, it could help to prevent potential overdose ...
(Date:11/27/2015)... ... ... No.1 Herpes-only dating community in the world, revealed that over 50% of its members are ... people under the age of 50 – or 67% of the population - are infected ... HSV-1 infection . , "The data shocks us highly!" said Michelle Li, Co-Founder of ...
(Date:11/27/2015)... ... November 27, 2015 , ... Keeping ... platform for mental health and wellness consultation, has collaborated with a leading web-based ... the knowledge gap experienced by parents and bring advice from parenting experts within ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... contact center software Q-Suite, announces the incorporation of Asterisk 11 LTS (Long Term ... fully supported Asterisk 11 LTS brings Q-Suite 5.10 up-to-date with a version of ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent Applied Drug ... need to integrate dose form selection in early phase drug development. The first ... supporting and bringing together the UK’s emerging life sciences companies, corporate partners, and ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... 2015 ... "2016 Global Tumor Marker Testing Market: ... Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, ... their offering. --> ) ... "2016 Global Tumor Marker Testing Market: Supplier ...
(Date:11/26/2015)... 2015 --> ... combineert immunotherapie met Bremachlorin-photodynamische therapie voor de ... ) --> ... ) Uit een ... (LUMC) blijkt dat ...
(Date:11/26/2015)... November 26, 2015 ... the "2016 Future Horizons and Growth ... Testing Market: Supplier Shares, Country Segment Forecasts, ... their offering. --> ) ... "2016 Future Horizons and Growth Strategies in ...
Breaking Medicine Technology: